Agenda

Considerations for Commercial Manufacturing of Peptides
14:00 - 14:45
Exhibitor Showcases (Free)
Vice President Business Development Asia
Bachem AG

Bachem’s company facts and highlights in 2016 will be presented. Find out why Bachem is your global partner for peptide APIs. There are key elements when it comes to commercial manufacturing of peptides. State of the art facilities, cutting edge equipment, know-how, raw materials, analytical methods, and GMP quality system. All these elements must work together in a holistic approach to achieve the best possible result for your API projects.

Regulatory Control of Finished Pharmaceutical Product in Malaysia: An Overview
14:30 - 15:20
Conference (Against a fee)
Senior Principal Assistant Director
NPRA

Control of Drugs and Cosmetics Regulations 1984 promulgated under the Sale of Drugs Act 1952 provide mandatory product registration and licensing of premises that deal with the said product.
The Drug Control Authority has been established for the purposes of these Regulations, where the National Pharmaceutical Regulatory Agency (NPRA) acts as its secretariat.
These presentations will provide you an overview of the regulating body, the legal basis and regulatory process for finished pharmaceutical product and provide an insight pertaining to finished pharmaceutical product registration in Malaysia.

The New Horizon of Immune Boosters
15:00 - 15:45
Exhibitor Showcases (Free)
Managing Director
STR Biotech

As the activity and safety of the immune enhancer increases, a new horizon of immune boosters is now opening. Immunity boosters will play a substantial and important role in the field like the allergic rhinitis, atopy, mild asthma, liver health, and resolution of anorexia (related to old age or cancer) in the future.

Registration of Finished Pharmaceutical Product in Malaysia
15:35 - 16:25
Conference (Against a fee)
Senior Principal Assistant Director
NPRA

Control of Drugs and Cosmetics Regulations 1984 promulgated under the Sale of Drugs Act 1952 provide mandatory product registration and licensing of premises that deal with the said product. The Drug Control Authority has been established for the purposes of these Regulations, where the National Pharmaceutical Regulatory Agency (NPRA) acts as its secretariat. These presentations will provide you an overview of the regulating body, the legal basis and regulatory process for finished pharmaceutical product and provide an insight pertaining to finished pharmaceutical product registration in Malaysia.

Overcoming Transportation Complexities and Challenges in USA & Security embedded transportation for Pharmaceutical Safety
16:00 - 16:45
Exhibitor Showcases (Free)
Life Sciences Manager
Brinks Global SVCS Korea LTD
Life Sciences Director
Brinks Global SVCS Korea LTD

Overcoming Transportation Complexities and Challenges in USA

The Americas include the largest pharma consumer market (the USA, and counties such as Brazil, Argentina, Mexico and Colombia where the demand for pharmaceutical therapies continues to grow).
During this section, you will learn about the complex pharma distribution landscape, and how to overcome some of the key challenges related to temperature management, regulatory compliance, and security. 

Security embedded transportation for Pharmaceutical safety

Pharmaceuticals is one of the main industries which requires security standards of transportation. Based on TAPA (The Transport Asset Protection Association) standards, we will look through what we can do to secure your supply chain for pharmaceutical safety.

Malaysian Market: Q&A
16:25 - 16:40
Conference (Against a fee)
Senior Principal Assistant Director
NPRA

Control of Drugs and Cosmetics Regulations 1984 promulgated under the Sale of Drugs Act 1952 provide mandatory product registration and licensing of premises that deal with the said product. The Drug Control Authority has been established for the purposes of these Regulations, where the National Pharmaceutical Regulatory Agency (NPRA) acts as its secretariat. These presentations will provide you an overview of the regulating body, the legal basis and regulatory process for finished pharmaceutical product and provide an insight pertaining to finished pharmaceutical product registration in Malaysia.